You are here

Article info

Article menu

Download PDFPDF

Introduction
Paper
The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction

Authors

  1. Correspondence to Professor Nir Eyal, Department of Global Health and Population, Harvard TH Chan School of Public Health, 651 Huntington Ave., FXB Building, Boston, MA 02139, USA; neyal{at}hsph.harvard.edu
View Full Text

Citation

Eyal N
The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
Journal of Medical Ethics 2017;43:65-66.

Publication history

  • Received February 1, 2016
  • Accepted February 8, 2016
  • First published May 23, 2016.
Online issue publication 
January 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Other content recommended for you